RetinalGenix Technologies (RetinalGenix Technologies) Operating Cash Flow per Share : $-0.02 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is RetinalGenix Technologies Operating Cash Flow per Share?

RetinalGenix Technologies's operating cash flow per share for the three months ended in Mar. 2024 was $-0.01. RetinalGenix Technologies's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 41.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for RetinalGenix Technologies's Operating Cash Flow per Share or its related term are showing as below:

RTGN' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 41.5 Med: 41.5 Max: 41.5
Current: 41.5

During the past 4 years, RetinalGenix Technologies's highest 3-Year average Operating Cash Flow per Share Growth Rate was 41.50% per year. The lowest was 41.50% per year. And the median was 41.50% per year.

RTGN's 3-Year OCF Growth Rate is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.55 vs RTGN: 41.50

RetinalGenix Technologies Operating Cash Flow per Share Historical Data

The historical data trend for RetinalGenix Technologies's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RetinalGenix Technologies Operating Cash Flow per Share Chart

RetinalGenix Technologies Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-0.10

-0.08

-0.01

-0.02

RetinalGenix Technologies Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial										-0.01	-0.01	-	-0.01	-0.01

Competitive Comparison of RetinalGenix Technologies's Operating Cash Flow per Share

For the Medical Devices subindustry, RetinalGenix Technologies's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RetinalGenix Technologies's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, RetinalGenix Technologies's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where RetinalGenix Technologies's Price-to-Operating-Cash-Flow falls into.

RetinalGenix Technologies Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

RetinalGenix Technologies's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-0.348	/	17.352
	=	-0.02

RetinalGenix Technologies's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	-0.143	/	17.672
	=	-0.01

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

RetinalGenix Technologies Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of RetinalGenix Technologies's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

RetinalGenix Technologies (RetinalGenix Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » RetinalGenix Technologies Inc (OTCPK:RTGN) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

1450 North McDowell Boulevard, Suite 150, Petaluma, CA, USA, 94954

Website

https://www.retinalgenix.com

RetinalGenix Technologies Inc is an ophthalmic research and development company focused on developing technologies to screen, monitor, diagnose, and treat ocular, optical, and sight-threatening disorders, Its mission is to prevent vision loss and blindness due to diabetic retinopathy and maculopathy through early detection from the use of two devices: (1) Retinal Imaging Screening Device (RetinalGenixTM), being designed as a portable, high-resolution retinal imaging Diabetic screening system providing a 200-degree field of view without requiring pupil dilation; and (2) RetinalCamTM, being designed as a high-resolution home monitoring retinal imaging device and physician alert system offering real-time communication with physicians available 24/7.